GeneVentiv Therapeutics to Attend BIO Europe Fall 2023

GeneVentiv Therapeutics to Attend BIO Europe Fall 2023

October 10, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood disorders, today announced it will attend BIO Europe Fall 2023, which will be held from November 14-15, 2023.  GeneVentiv...
GeneVentiv to Attend BIO Investor Forum

GeneVentiv to Attend BIO Investor Forum

October 2, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood disorders, today announced it will attend BIO Investor Forum, which will be held in San Francisco, CA from October 17-18,...